Previous researches also showed that the downstream factors of ErbB pathway, such as MMP-9, uPA, EMMPRIN, and PAI-1, could be induced by AREG in head and neck cancer [28, 29], breast cancer [59, 60], and malignant mesothelioma cell lines [61]. Here, PLAU is linked to breast carcinoma.